Ask AI
ProCE Banner Activity

CCO Think Tank on Emerging HER2-Targeted ADCs: Genitourinary Malignancies

Slideset

Slides from Elizabeth Plimack, MD, covering the recent developments in HER2 testing, clinical trial results for anti-HER2 antibody-drug conjugate (ADC) therapy, and current strategies on managing the safety profile of ADCs.

Released: March 22, 2024

Expiration: March 21, 2025

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.